APA (7th ed.) Citation

Liu, X., Mo, M., Fan, L., & Shao, Z. (2025). 398P Patient-reported outcomes (PROs) with GnRHa as ovarian function suppression (OFS) treatment in pre-menopausal Chinese patients with hormone receptor-positive (HR+) early breast cancer (EBC): A real-world observational investigation. Annals of Oncology, 36, S367. https://doi.org/10.1016/j.annonc.2025.08.822

Chicago Style (17th ed.) Citation

Liu, X., M. Mo, L. Fan, and Z. Shao. "398P Patient-reported Outcomes (PROs) with GnRHa as Ovarian Function Suppression (OFS) Treatment in Pre-menopausal Chinese Patients with Hormone Receptor-positive (HR+) Early Breast Cancer (EBC): A Real-world Observational Investigation." Annals of Oncology 36 (2025): S367. https://doi.org/10.1016/j.annonc.2025.08.822.

MLA (9th ed.) Citation

Liu, X., et al. "398P Patient-reported Outcomes (PROs) with GnRHa as Ovarian Function Suppression (OFS) Treatment in Pre-menopausal Chinese Patients with Hormone Receptor-positive (HR+) Early Breast Cancer (EBC): A Real-world Observational Investigation." Annals of Oncology, vol. 36, 2025, p. S367, https://doi.org/10.1016/j.annonc.2025.08.822.